​

CVS Health (CVS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CVS Stock Forecast

CVS Health (CVS) stock forecast, based on 41 Wall Street analysts, predicts a 12-month average price target of $91.00, with a high of $103.00 and a low of $82.00. This represents a 10.71% increase from the last price of $82.20.

$40 $53 $66 $79 $92 $105 High: $103 Avg: $91 Low: $82 Last Closed Price: $82.2

CVS Stock Rating

CVS Health stock's rating consensus is Buy, based on 41 Wall Street analysts. The breakdown includes 2 Strong Buy (4.88%), 32 Buy (78.05%), 7 Hold (17.07%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 41 0 7 32 2 Strong Sell Sell Hold Buy Strong Buy

CVS Price Target Upside V Benchmarks

TypeNameUpside
StockCVS Health10.71%
SectorHealthcare Stocks 15.45%
IndustryHealthcare Plans Stocks11.69%

Price Target Trends

1M3M12M
# Anlaysts6913
Avg Price Target$93.17$89.67$84.23
Last Closing Price$82.20$82.20$82.20
Upside/Downside13.35%9.09%2.47%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 257154--26
Sep, 257145--26
Aug, 257137--27
Jul, 258137--28
Jun, 258137--28
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 24, 2025UBS$96.00$81.0718.42%16.79%
Oct 14, 2025David MacDonaldTruist Financial$92.00$79.2616.07%11.92%
Oct 14, 2025Erin WrightMorgan Stanley$89.00$78.8212.92%8.27%
Oct 14, 2025Goldman Sachs$91.00$78.4416.01%10.71%
Oct 09, 2025Ann HynesMizuho Securities$88.00$76.9314.39%7.06%
Oct 07, 2025Wells Fargo$103.00$76.8434.04%25.30%
Sep 04, 2025Andrew MokBarclays$87.00$73.3218.66%5.84%
Aug 18, 2025Kevin CaliendoUBS$79.00$68.6015.16%-3.89%
Aug 14, 2025Michael HaRobert W. Baird$82.00$66.5823.16%-0.24%
Jun 02, 2025Andrew MokBarclays$79.00$63.6024.21%-3.89%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 24, 2025UBSBuyBuyhold
Oct 14, 2025Morgan StanleyOverweightOverweighthold
Oct 14, 2025Goldman SachsNeutralBuyinitialise
Oct 07, 2025Wells FargoOverweightOverweighthold
Sep 04, 2025BarclaysOverweightOverweighthold
Aug 18, 2025UBSUnderperformBuyupgrade
Aug 04, 2025Cowen & Co.BuyBuyhold
Jun 02, 2025BarclaysOverweightOverweighthold
May 06, 2025Wells FargoOverweightOverweighthold
Apr 15, 2025Morgan StanleyOverweightOverweighthold

Financial Forecast

EPS Forecast

$3 $4 $5 $6 $7 $8 $9 $10 $11 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$5.48$6.00$3.29$6.49$3.66----
Avg Forecast$7.44$8.25$8.63$8.61$5.15$5.87$6.88$8.19$10.15
High Forecast$7.60$8.43$8.95$8.64$5.81$7.03$8.43$8.98$10.69
Low Forecast$7.29$8.09$8.32$8.59$4.65$5.34$5.83$7.49$9.66
Surprise %-26.34%-27.27%-61.88%-24.62%-28.93%----

Revenue Forecast

$250B $300B $350B $400B $450B $500B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$268.71B$292.11B$322.47B$357.78B$372.81B----
Avg Forecast$267.95B$290.59B$315.12B$354.36B$371.88B$385.40B$405.34B$421.93B$443.77B
High Forecast$272.43B$295.45B$324.21B$356.91B$373.69B$401.00B$405.76B$424.16B$461.94B
Low Forecast$263.76B$286.05B$306.42B$351.62B$367.69B$372.45B$404.92B$419.69B$427.19B
Surprise %0.28%0.52%2.33%0.96%0.25%----

Net Income Forecast

$4B $6B $8B $10B $12B $14B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$7.18B$8.00B$4.31B$8.34B$4.61B----
Avg Forecast$5.39B$6.83B$7.85B$8.34B$6.75B$7.97B$9.20B$10.62B$13.09B
High Forecast$6.47B$8.19B$9.42B$10.01B$7.50B$9.06B$10.88B$11.58B$13.79B
Low Forecast$4.31B$5.46B$6.28B$6.68B$6.00B$6.88B$7.52B$9.66B$12.46B
Surprise %33.22%17.17%-45.10%--31.65%----

CVS Forecast FAQ

Is CVS Health stock a buy?

CVS Health stock has a consensus rating of Buy, based on 41 Wall Street analysts. The rating breakdown includes 2 Strong Buy, 32 Buy, 7 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that CVS Health is a favorable investment for most analysts.

What is CVS Health's price target?

CVS Health's price target, set by 41 Wall Street analysts, averages $91 over the next 12 months. The price target range spans from $82 at the low end to $103 at the high end, suggesting a potential 10.71% change from the previous closing price of $82.2.

How does CVS Health stock forecast compare to its benchmarks?

CVS Health's stock forecast shows a 10.71% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the healthcare plans stocks industry (11.69%).

What is the breakdown of analyst ratings for CVS Health over the past three months?

  • October 2025: 26.92% Strong Buy, 57.69% Buy, 15.38% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 26.92% Strong Buy, 53.85% Buy, 19.23% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 25.93% Strong Buy, 48.15% Buy, 25.93% Hold, 0% Sell, 0% Strong Sell.

What is CVS Health’s EPS forecast?

CVS Health's average annual EPS forecast for its fiscal year ending in December 2025 is $5.87, marking a 60.38% increase from the reported $3.66 in 2024. Estimates for the following years are $6.88 in 2026, $8.19 in 2027, and $10.15 in 2028.

What is CVS Health’s revenue forecast?

CVS Health's average annual revenue forecast for its fiscal year ending in December 2025 is $385.4B, reflecting a 3.38% increase from the reported $372.81B in 2024. The forecast for 2026 is $405.34B, followed by $421.93B for 2027, and $443.77B for 2028.

What is CVS Health’s net income forecast?

CVS Health's net income forecast for the fiscal year ending in December 2025 stands at $7.97B, representing an 72.83% increase from the reported $4.61B in 2024. Projections indicate $9.2B in 2026, $10.62B in 2027, and $13.09B in 2028.